Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
IRIS
Background: In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15–39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods: Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15–39 years to define adolescents and young adults. Findings: There were 1·19 million (95% UI 1·11–1·28) incident cancer cases and 396 000 (370 000–425 000) deaths due to cancer among people aged 15–39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59·6 [54·5–65·7] per 100 000 person-years) and high-middle SDI countries (53·2 [48·8–57·9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14·2 [12·9–15·6] per 100 000 person-years) and middle SDI (13·6 [12·6–14·8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23·5 million (21·9–25·2) DALYs to the global burden of disease, of which 2·7% (1·9–3·6) came from YLDs and 97·3% (96·4–98·1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation: Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Funding: Bill & Melinda Gates Foundation, American Lebanese Syrian Associated Charities, St Baldrick's Foundation, and the National Cancer Institute.
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019
Alvarez E. M.;Force L. M.;Xu R.;Compton K.;Lu D.;Henrikson H. J.;Kocarnik J. M.;Harvey J. D.;Pennini A.;Dean F. E.;Fu W.;Vargas M. T.;Keegan T. H. M.;Ariffin H.;Barr R. D.;Erdomaeva Y. A.;Gunasekera D. S.;John-Akinola Y. O.;Ketterl T. G.;Kutluk T.;Malogolowkin M. H.;Mathur P.;Radhakrishnan V.;Ries L. A. G.;Rodriguez-Galindo C.;Sagoyan G. B.;Sultan I.;Abbasi B.;Abbasi-Kangevari M.;Abbasi-Kangevari Z.;Abbastabar H.;Abdelmasseh M.;Abd-Elsalam S.;Abdoli A.;Abebe H.;Abedi A.;Abidi H.;Abolhassani H.;Abubaker Ali H.;Abu-Gharbieh E.;Achappa B.;Acuna J. M.;Adedeji I. A.;Adegboye O. A.;Adnani Q. E. S.;Advani S. M.;Afzal M. S.;Aghaie Meybodi M.;Ahadinezhad B.;Ahinkorah B. O.;Ahmad S.;Ahmadi S.;Ahmed M. B.;Ahmed Rashid T.;Ahmed Salih Y.;Aiman W.;Akalu G. T.;Al Hamad H.;Alahdab F.;AlAmodi A. A.;Alanezi F. M.;Alanzi T. M.;Alem A. Z.;Alem D. T.;Alemayehu Y.;Alhalaiqa F. N.;Alhassan R. K.;Ali S.;Alicandro G.;Alipour V.;Aljunid S. M.;Alkhayyat M.;Alluri S.;Almasri N. A.;Al-Maweri S. A.;Almustanyir S.;Al-Raddadi R. M.;Alvis-Guzman N.;Ameyaw E. K.;Amini S.;Amu H.;Ancuceanu R.;Andrei C. L.;Andrei T.;Ansari F.;Ansari-Moghaddam A.;Anvari D.;Anyasodor A. E.;Arabloo J.;Arab-Zozani M.;Argaw A. M.;Arshad M.;Arulappan J.;Aryannejad A.;Asemi Z.;Asghari Jafarabadi M.;Atashzar M. R.;Atorkey P.;Atreya A.;Attia S.;Aujayeb A.;Ausloos M.;Avila-Burgos L.;Awedew A. F.;Ayala Quintanilla B. P.;Ayele A. D.;Ayen S. S.;Azab M. A.;Azadnajafabad S.;Azami H.;Azangou-Khyavy M.;Azari Jafari A.;Azarian G.;Azzam A. Y.;Bahadory S.;Bai J.;Baig A. A.;Baker J. L.;Banach M.;Barnighausen T. W.;Barone-Adesi F.;Barra F.;Barrow A.;Basaleem H.;Batiha A. -M. M.;Behzadifar M.;Bekele N. C.;Belete R.;Belgaumi U. I.;Bell A. W.;Berhie A. Y.;Bhagat D. S.;Bhagavathula A. S.;Bhardwaj N.;Bhardwaj P.;Bhaskar S.;Bhattacharyya K.;Bhojaraja V. S.;Bibi S.;Bijani A.;Biondi A.;Birara S.;Bjorge T.;Bolarinwa O. A.;Bolla S. R.;Boloor A.;Braithwaite D.;Brenner H.;Bulamu N. B.;Burkart K.;Bustamante-Teixeira M. T.;Butt N. S.;Butt Z. A.;Caetano dos Santos F. L.;Cao C.;Cao Y.;Carreras G.;Catala-Lopez F.;Cembranel F.;Cerin E.;Chakinala R. C.;Chakraborty P. A.;Chattu V. K.;Chaturvedi P.;Chaurasia A.;Chavan P. P.;Chimed-Ochir O.;Choi J. -Y. J.;Christopher D. J.;Chu D. -T.;Chung M. T.;Conde J.;Costa V. M.;Da'ar O. B.;Dadras O.;Dahlawi S. M. A.;Dai X.;Damiani G.;D'Amico E.;Dandona L.;Dandona R.;Daneshpajouhnejad P.;Darwish A. H.;Daryani A.;De la Hoz F. P.;Debela S. A.;Demie T. G. G.;Demissie G. D.;Demissie Z. G.;Denova-Gutierrez E.;Derbew Molla M.;Desai R.;Desta A. A.;Dhamnetiya D.;Dharmaratne S. D.;Dhimal M. L.;Dhimal M.;Dianatinasab M.;Didehdar M.;Diress M.;Djalalinia S.;Do H. P.;Doaei S.;Dorostkar F.;dos Santos W. M.;Drake T. M.;Ekholuenetale M.;El Sayed I.;El Sayed Zaki M.;El Tantawi M.;El-Abid H.;Elbahnasawy M. A.;Elbarazi I.;Elhabashy H. R.;Elhadi M.;El-Jaafary S. I.;Enyew D. B.;Erkhembayar R.;Eshrati B.;Eskandarieh S.;Faisaluddin M.;Fares J.;Farooque U.;Fasanmi A. O.;Fatima W.;Ferreira de Oliveira J. M. P.;Ferrero S.;Ferro Desideri L.;Fetensa G.;Filip I.;Fischer F.;Fisher J. L.;Foroutan M.;Fukumoto T.;Gaal P. A.;Gad M. M.;Gaewkhiew P.;Gallus S.;Garg T.;Gebremeskel T. G.;Gemeda B. N. B.;Getachew T.;Ghafourifard M.;Ghamari S. -H.;Ghashghaee A.;Ghassemi F.;Ghith N.;Gholami A.;Gholizadeh Navashenaq J.;Gilani S. A.;Ginindza T. G.;Gizaw A. T.;Glasbey J. C.;Goel A.;Golechha M.;Goleij P.;Golinelli D.;Gopalani S. V.;Gorini G.;Goudarzi H.;Goulart B. N. G.;Grada A.;Gubari M. I. M.;Guerra M. R.;Guha A.;Gupta B.;Gupta S.;Gupta V. B.;Gupta V. K.;Haddadi R.;Hafezi-Nejad N.;Hailu A.;Haj-Mirzaian A.;Halwani R.;Hamadeh R. R.;Hambisa M. T.;Hameed S.;Hamidi S.;Haque S.;Hariri S.;Haro J. M.;Hasaballah A. I.;Hasan S. M. M.;Hashemi S. M.;Hassan T. S.;Hassanipour S.;Hay S. I.;Hayat K.;Hebo S. H.;Heidari G.;Heidari M.;Herrera-Serna B. Y.;Herteliu C.;Heyi D. Z.;Hezam K.;Hole M. K.;Holla R.;Horita N.;Hossain M. M.;Hossain M. B.;Hosseini M. -S.;Hosseini M.;Hosseinzadeh A.;Hosseinzadeh M.;Hostiuc M.;Hostiuc S.;Househ M.;Hsairi M.;Huang J.;Hussein N. R.;Hwang B. -F.;Ibitoye S. E.;Ilesanmi O. S.;Ilic I. M.;Ilic M. D.;Innos K.;Irham L. M.;Islam R. M.;Islam S. M. S.;Ismail N. E.;Isola G.;Iwagami M.;Jacob L.;Jadidi-Niaragh F.;Jain V.;Jakovljevic M.;Janghorban R.;Javadi Mamaghani A.;Jayaram S.;Jayawardena R.;Jazayeri S. B.;Jebai R.;Jha R. P.;Joo T.;Joseph N.;Joukar F.;Jurisson M.;Kaambwa B.;Kabir A.;Kalankesh L. R.;Kaliyadan F.;Kamal Z.;Kamath A.;Kandel H.;Kar S. S.;Karaye I. M.;Karimi A.;Kassa B. G.;Kauppila J. H.;Kemp Bohan P. M.;Kengne A. P.;Kerbo A. A.;Keykhaei M.;Khader Y. S.;Khajuria H.;Khalili N.;Khalili N.;Khan E. A.;Khan G.;Khan M.;Khan M. N.;Khan M. A.;Khanali J.;Khayamzadeh M.;Khosravizadeh O.;Khubchandani J.;Khundkar R.;Kim M. S.;Kim Y. J.;Kisa A.;Kisa S.;Kissimova-Skarbek K.;Kolahi A. -A.;Kopec J. A.;Koteeswaran R.;Koulmane Laxminarayana S. L.;Koyanagi A.;Kugbey N.;Kumar G. A.;Kumar N.;Kwarteng A.;La Vecchia C.;Lan Q.;Landires I.;Lasrado S.;Lauriola P.;Ledda C.;Lee S. -W.;Lee W. -C.;Lee Y. Y.;Lee Y. H.;Leigh J.;Leong E.;Li B.;Li J.;Li M. -C.;Lim S. S.;Liu X.;Lobo S. W.;Loureiro J. A.;Lugo A.;Lunevicius R.;Magdy Abd El Razek H.;Magdy Abd El Razek M.;Mahmoudi M.;Majeed A.;Makki A.;Male S.;Malekpour M. -R.;Malekzadeh R.;Malik A. A.;Mamun M. A.;Manafi N.;Mansour-Ghanaei F.;Mansouri B.;Mansournia M. A.;Martini S.;Masoumi S. Z.;Matei C. N.;Mathur M. R.;McAlinden C.;Mehrotra R.;Mendoza W.;Menezes R. G.;Mentis A. -F. A.;Meretoja T. J.;Mersha A. G.;Mesregah M. K.;Mestrovic T.;Miao Jonasson J.;Miazgowski B.;Michalek I. M.;Miller T. R.;Mingude A. B.;Mirmoeeni S.;Mirzaei H.;Misra S.;Mithra P.;Mohammad K. A.;Mohammadi M.;Mohammadi S. M.;Mohammadian-Hafshejani A.;Mohammadpourhodki R.;Mohammed A.;Mohammed S.;Mohammed T. A.;Moka N.;Mokdad A. H.;Molokhia M.;Momtazmanesh S.;Monasta L.;Moni M. A.;Moradi G.;Moradi Y.;Moradzadeh M.;Moradzadeh R.;Moraga P.;Morrison S. D.;Mostafavi E.;Mousavi Khaneghah A.;Mpundu-Kaambwa C.;Mubarik S.;Mwanri L.;Nabhan A. F.;Nagaraju S. P.;Nagata C.;Naghavi M.;Naimzada M. D.;Naldi L.;Nangia V.;Naqvi A. A.;Narasimha Swamy S.;Narayana A. I.;Nayak B. P.;Nayak V. C.;Nazari J.;Nduaguba S. O.;Negoi I.;Negru S. M.;Nejadghaderi S. A.;Nepal S.;Neupane Kandel S.;Nggada H. A.;Nguyen C. T.;Nnaji C. A.;Nosrati H.;Nouraei H.;Nowroozi A.;Nunez-Samudio V.;Nwatah V. E.;Nzoputam C. I.;Oancea B.;Odukoya O. O.;Oguntade A. S.;Oh I. -H.;Olagunju A. T.;Olagunju T. O.;Olakunde B. O.;Oluwasanu M. M.;Omar E.;Omar Bali A.;Ong S.;Onwujekwe O. E.;Ortega-Altamirano D. V.;Otstavnov N.;Otstavnov S. S.;Oumer B.;Owolabi M. O.;P A M.;Padron-Monedero A.;Padubidri J. R.;Pakshir K.;Pana A.;Pandey A.;Pardhan S.;Pashazadeh Kan F.;Pasovic M.;Patel J. R.;Pati S.;Pattanshetty S. M.;Paudel U.;Pereira R. B.;Peres M. F. P.;Perianayagam A.;Postma M. J.;Pourjafar H.;Pourshams A.;Prashant A.;Pulakunta T.;Qadir M. M. F. F.;Rabiee M.;Rabiee N.;Radfar A.;Radhakrishnan R. A.;Rafiee A.;Rafiei A.;Rafiei S.;Rahim F.;Rahimzadeh S.;Rahman M.;Rahman M. A.;Rahmani A. M.;Rajesh A.;Ramezani-Doroh V.;Ranabhat K.;Ranasinghe P.;Rao C. R.;Rao S. J.;Rashedi S.;Rashidi M.;Rashidi M. -M.;Rath G. K.;Rawaf D. L.;Rawaf S.;Rawal L.;Rawassizadeh R.;Razeghinia M. S.;Regasa M. T.;Renzaho A. M. N.;Rezaei M.;Rezaei N.;Rezaei N.;Rezaeian M.;Rezapour A.;Rezazadeh-Khadem S.;Riad A.;Rios Lopez L. E.;Rodriguez J. A. B.;Ronfani L.;Roshandel G.;Rwegerera G. M.;Saber-Ayad M. M.;Sabour S.;Saddik B.;Sadeghi E.;Sadeghian S.;Saeed U.;Sahebkar A.;Saif-Ur-Rahman K. M.;Sajadi S. M.;Salahi S.;Salehi S.;Salem M. R.;Salimzadeh H.;Samy A. M.;Sanabria J.;Sanmarchi F.;Sarveazad A.;Sathian B.;Sawhney M.;Sawyer S. M.;Saylan M.;Schneider I. J. C.;Seidu A. -A.;Sekerija M.;Sendo E. G.;Sepanlou S. G.;Seylani A.;Seyoum K.;Sha F.;Shafaat O.;Shaikh M. A.;Shamsoddin E.;Shannawaz M.;Sharma R.;Sheikhbahaei S.;Shetty A.;Shetty B. S. K.;Shetty P. H.;Shin J. I.;Shirkoohi R.;Shivakumar K. M.;Shobeiri P.;Siabani S.;Sibhat M. M.;Siddappa Malleshappa S. K.;Sidemo N. B.;Silva D. A. S.;Silva Julian G.;Singh A. D.;Singh J. A.;Singh J. K.;Singh S.;Sinke A. H.;Sintayehu Y.;Skryabin V. Y.;Skryabina A. A.;Smith L.;Sofi-Mahmudi A.;Soltani-Zangbar M. S.;Song S.;Spurlock E. E.;Steiropoulos P.;Straif K.;Subedi R.;Sufiyan M. B.;Suliankatchi Abdulkader R.;Sultana S.;Szerencses V.;Szocska M.;Tabaeian S. P.;Tabares-Seisdedos R.;Tabary M.;Tabuchi T.;Tadbiri H.;Taheri M.;Taherkhani A.;Takahashi K.;Tampa M.;Tan K. -K.;Tat V. Y.;Tavakoli A.;Tbakhi A.;Tehrani-Banihashemi A.;Temsah M. -H.;Tesfay F. H.;Tesfaye B.;Thakur J. S.;Thapar R.;Thavamani A.;Thiyagarajan A.;Thomas N.;Tobe-Gai R.;Togtmol M.;Tohidast S. A.;Tohidinik H. R.;Tolani M. A.;Tollosa D. N.;Touvier M.;Tovani-Palone M. R.;Traini E.;Tran B. X.;Tran M. T. N.;Tripathy J. P.;Tusa B. S.;Ukke G. G.;Ullah I.;Ullah S.;Umapathi K. K.;Unnikrishnan B.;Upadhyay E.;Ushula T. W.;Vacante M.;Valadan Tahbaz S.;Varthya S. B.;Veroux M.;Villeneuve P. J.;Violante F. S.;Vlassov V.;Vu G. T.;Waheed Y.;Wang N.;Ward P.;Weldesenbet A. B.;Wen Y. F.;Westerman R.;Winkler A. S.;Wubishet B. L.;Xu S.;Yahyazadeh Jabbari S. H.;Yang L.;Yaya S.;Yazdi-Feyzabadi V.;Yazie T. S.;Yehualashet S. S.;Yeshaneh A.;Yeshaw Y.;Yirdaw B. W.;Yonemoto N.;Younis M. Z.;Yousefi Z.;Yu C.;Yunusa I.;Zadnik V.;Zahir M.;Zahirian Moghadam T.;Zamani M.;Zamanian M.;Zandian H.;Zare F.;Zastrozhin M. S.;Zastrozhina A.;Zhang J.;Zhang Z. -J.;Ziapour A.;Zoladl M.;Murray C. J. L.;Fitzmaurice C.;Bleyer A.;Bhakta N.
2022-01-01
Abstract
Background: In estimating the global burden of cancer, adolescents and young adults with cancer are often overlooked, despite being a distinct subgroup with unique epidemiology, clinical care needs, and societal impact. Comprehensive estimates of the global cancer burden in adolescents and young adults (aged 15–39 years) are lacking. To address this gap, we analysed results from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, with a focus on the outcome of disability-adjusted life-years (DALYs), to inform global cancer control measures in adolescents and young adults. Methods: Using the GBD 2019 methodology, international mortality data were collected from vital registration systems, verbal autopsies, and population-based cancer registry inputs modelled with mortality-to-incidence ratios (MIRs). Incidence was computed with mortality estimates and corresponding MIRs. Prevalence estimates were calculated using modelled survival and multiplied by disability weights to obtain years lived with disability (YLDs). Years of life lost (YLLs) were calculated as age-specific cancer deaths multiplied by the standard life expectancy at the age of death. The main outcome was DALYs (the sum of YLLs and YLDs). Estimates were presented globally and by Socio-demographic Index (SDI) quintiles (countries ranked and divided into five equal SDI groups), and all estimates were presented with corresponding 95% uncertainty intervals (UIs). For this analysis, we used the age range of 15–39 years to define adolescents and young adults. Findings: There were 1·19 million (95% UI 1·11–1·28) incident cancer cases and 396 000 (370 000–425 000) deaths due to cancer among people aged 15–39 years worldwide in 2019. The highest age-standardised incidence rates occurred in high SDI (59·6 [54·5–65·7] per 100 000 person-years) and high-middle SDI countries (53·2 [48·8–57·9] per 100 000 person-years), while the highest age-standardised mortality rates were in low-middle SDI (14·2 [12·9–15·6] per 100 000 person-years) and middle SDI (13·6 [12·6–14·8] per 100 000 person-years) countries. In 2019, adolescent and young adult cancers contributed 23·5 million (21·9–25·2) DALYs to the global burden of disease, of which 2·7% (1·9–3·6) came from YLDs and 97·3% (96·4–98·1) from YLLs. Cancer was the fourth leading cause of death and tenth leading cause of DALYs in adolescents and young adults globally. Interpretation: Adolescent and young adult cancers contributed substantially to the overall adolescent and young adult disease burden globally in 2019. These results provide new insights into the distribution and magnitude of the adolescent and young adult cancer burden around the world. With notable differences observed across SDI settings, these estimates can inform global and country-level cancer control efforts. Funding: Bill & Melinda Gates Foundation, American Lebanese Syrian Associated Charities, St Baldrick's Foundation, and the National Cancer Institute.
Adolescent Adult Cause of Death Disability-Adjusted Life Years Female Global Burden of Disease Humans Incidence Life Expectancy Male Mortality Neoplasms Prevalence Risk Factors Socioeconomic Factors Young Adult Global Health
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14085/19201
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Citazioni
ND
135
ND
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2023-2025 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.
